tradingkey.logo

LivaNova PLC

LIVN
56.830USD
+2.890+5.36%
Fechamento 11/04, 16:00ETCotações atrasadas em 15 min
3.10BValor de mercado
PerdaP/L TTM

Mais detalhes de LivaNova PLC Empresa

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.

Informações de LivaNova PLC

Código da empresaLIVN
Nome da EmpresaLivaNova PLC
Data de listagemOct 19, 2015
CEOMr. Vladimir A. Makatsaria
Número de funcionários2900
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 19
Endereço20 Eastbourne Terrace
CidadeLONDON
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited Kingdom
Código postalW2 6LG
Telefone442033250662
Sitehttps://www.livanova.com/
Código da empresaLIVN
Data de listagemOct 19, 2015
CEOMr. Vladimir A. Makatsaria

Executivos da empresa LivaNova PLC

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
32.57K
+15.05%
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
26.68K
--
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
12.75K
--
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
+19.06%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
9.06K
+49.63%
Mr. Francesco Bianchi
Mr. Francesco Bianchi
Independent Director
Independent Director
9.03K
-14.25%
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
8.52K
+4.49%
Ms. Brooke Story
Ms. Brooke Story
Independent Director
Independent Director
6.48K
+86.48%
Mr. Michael Damon Hutchinson
Mr. Michael Damon Hutchinson
Senior Vice President, Chief Legal Officer, Company Secretary
Senior Vice President, Chief Legal Officer, Company Secretary
5.67K
--
Ahmet Tezel
Ahmet Tezel
Senior Vice President, Chief Innovation Officer
Senior Vice President, Chief Innovation Officer
1.94K
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
32.57K
+15.05%
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
26.68K
--
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
12.75K
--
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
+19.06%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
9.06K
+49.63%
Mr. Francesco Bianchi
Mr. Francesco Bianchi
Independent Director
Independent Director
9.03K
-14.25%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
188.47M
53.46%
Rest of World
97.27M
27.59%
Europe
66.78M
18.94%
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: ter, 19 de ago
Atualizado em: ter, 19 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.67%
PRIMECAP Management Company
8.50%
The Vanguard Group, Inc.
4.47%
Millennium Management LLC
4.44%
State Street Investment Management (US)
3.81%
Outro
67.10%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.67%
PRIMECAP Management Company
8.50%
The Vanguard Group, Inc.
4.47%
Millennium Management LLC
4.44%
State Street Investment Management (US)
3.81%
Outro
67.10%
Tipos de investidores
Investidores
Proporção
Investment Advisor
47.30%
Investment Advisor/Hedge Fund
34.79%
Hedge Fund
15.49%
Research Firm
2.72%
Pension Fund
2.17%
Bank and Trust
1.36%
Individual Investor
0.36%
Sovereign Wealth Fund
0.09%
Insurance Company
0.04%

Participação acionária institucional

Atualizado em: dom, 5 de out
Atualizado em: dom, 5 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
561
56.75M
103.93%
-8.11M
2025Q2
564
56.85M
104.11%
-6.95M
2025Q1
581
56.61M
103.82%
-8.04M
2024Q4
586
56.98M
104.84%
-8.56M
2024Q3
563
55.15M
101.56%
-9.48M
2024Q2
546
57.21M
105.64%
-8.52M
2024Q1
547
58.00M
107.51%
-6.90M
2023Q4
532
56.62M
105.11%
-7.28M
2023Q3
527
56.14M
104.20%
-8.51M
2023Q2
529
55.56M
103.33%
-9.55M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
6.37M
11.67%
-150.58K
-2.31%
Jun 30, 2025
PRIMECAP Management Company
4.64M
8.5%
+32.94K
+0.71%
Jun 30, 2025
The Vanguard Group, Inc.
2.44M
4.47%
-214.69K
-8.09%
Jun 30, 2025
Millennium Management LLC
2.43M
4.44%
+360.76K
+17.47%
Jun 30, 2025
State Street Investment Management (US)
2.08M
3.81%
-17.41K
-0.83%
Jun 30, 2025
AQR Capital Management, LLC
2.05M
3.75%
+478.52K
+30.45%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.61M
2.96%
+282.33K
+21.20%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.43M
2.62%
+18.55K
+1.31%
Jun 30, 2025
Wellington Management Company, LLP
1.28M
2.34%
+805.32K
+170.32%
Jun 30, 2025
Artisan Partners Limited Partnership
1.25M
2.29%
+661.48K
+112.86%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: dom, 2 de nov
Atualizado em: dom, 2 de nov
Nome
Proporção
SPDR S&P Health Care Equipment ETF
1.52%
JPMorgan Active Small Cap Value ETF
1.19%
Federated Hermes MDT Small Cap Core ETF
0.56%
Invesco NASDAQ Future Gen 200 ETF
0.45%
Global X Aging Population ETF
0.41%
Simplify Health Care ETF
0.4%
iShares US Small Cap Value Factor ETF
0.36%
Avantis US Small Cap Equity ETF
0.33%
iShares U.S. Medical Devices ETF
0.33%
First Trust Active Factor Mid Cap ETF
0.32%
Ver Mais
SPDR S&P Health Care Equipment ETF
Proporção1.52%
JPMorgan Active Small Cap Value ETF
Proporção1.19%
Federated Hermes MDT Small Cap Core ETF
Proporção0.56%
Invesco NASDAQ Future Gen 200 ETF
Proporção0.45%
Global X Aging Population ETF
Proporção0.41%
Simplify Health Care ETF
Proporção0.4%
iShares US Small Cap Value Factor ETF
Proporção0.36%
Avantis US Small Cap Equity ETF
Proporção0.33%
iShares U.S. Medical Devices ETF
Proporção0.33%
First Trust Active Factor Mid Cap ETF
Proporção0.32%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI